Personal Care Products

Waldencast

Waldencast released FY2025 Q3 earnings on March 13 After-Market EST, actual revenue USD 69.9 M (forecast USD 67.8 M), actual EPS USD -0.2607 (forecast USD -0.1366)

Waldencast released FY2025 9 Months Earnings on March 13 After-Market EST, actual revenue USD 202.17 M, actual EPS USD -1.7707

Waldencast released FY2025 annual earnings on March 13 Pre-Market EST, actual revenue USD 272.07 M (forecast USD 272.85 M), actual EPS USD -2.0141 (forecast USD -1.9266)

Waldencast released FY2025 Q4 earnings on March 13 Pre-Market (EST), actual revenue USD 69.9 M (forecast USD 72.79 M), actual EPS USD -0.2607 (forecast USD -0.08)

Waldencast to Release FY2025 Q4 Earnings on March 13 Pre-Market EST, Forecast Revenue USD 72.79 M, EPS USD -0.08

Waldencast plc Launches ALOHA Program to Generate Real-World Evidence for Injectable Product

Waldencast released FY2025 Semi-Annual earnings on November 24 After-Market EST, actual revenue USD 132.27 M, actual EPS USD -1.51

Waldencast released FY2025 Q2 earnings on November 24 After-Market EST, actual revenue USD 66.14 M (forecast USD 66.65 M), actual EPS USD -0.755 (forecast USD -0.1)

Waldencast released FY2025 Q1 earnings on November 24 After-Market (EST), actual revenue USD 66.14 M (forecast USD 68.01 M), actual EPS USD -0.755 (forecast USD -0.08)

Waldencast to Release FY2025 Q3 Earnings on November 10 After-Market EST, Forecast Revenue USD 77.63 M, EPS USD -0.08

Waldencast to Release FY2025 Q2 Earnings on August 17 After-Market EST, Forecast Revenue USD 71.94 M, EPS USD -0.0966

Canadian Investment Bank Maintains Waldencast Rating, Adjusts Target Price to $5.00

Telsey Advisory Group adjusts Waldencast stock rating

Waldencast PLC Expected to Report Quarterly EPS Loss of 4 Cents

Telsey Maintains Waldencast Outperform Rating

Waldencast to Release FY2025 Q1 Earnings on May 13 After-Market EST, Forecast Revenue USD 68.01 M, EPS USD -0.0325

Waldencast plc Receives 'Moderate Buy' Consensus Rating from Analysts

Waldencast released FY2024 earnings on March 20 After-Market EST, actual revenue USD 273.87 M (forecast USD 272.49 M), actual EPS USD -0.3899 (forecast USD -0.2)

Waldencast released FY2024 Q3 earnings on March 20 After-Market (EST), actual revenue USD 71.14 M (forecast USD 68.74 M), actual EPS USD -0.1481 (forecast USD -0.06)

Waldencast released FY2024 Q4 earnings on March 20 After-Market EST, actual revenue USD 71.14 M (forecast USD 70.68 M), actual EPS USD -0.1481 (forecast USD -0.036)

Netcapital

Agape ATP

Tradr 2X Long QBTS Daily ETF

Akanda

Defiance Daily Target 2X Long RGTI ETF

PicoCELA

Tradr 2X Long RGTI Daily ETF

Co-Diagnostics

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NewGenIvf

WALD

Obagi Medical presented new data at the Music City SCALE meeting, showcasing the efficacy of its NU-GEN Cellular Renewal Serum and the Obagi Saypha® MagIQ™ dermal filler. Interim results from the ALOHA Program indicate that 94% of injectors find MagIQ™ complements their current offerings, with 43% of patients also considering Obagi skincare. The NU-GEN serum is clinically proven to reduce visible signs of aging. Obagi Medical aims to enhance practice success through innovative skincare solutions.

StockTitan

WALDENCAST PLC C/WTS 27/07/2027 (TO PUR ORD)

Obagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting | WALD Stock News

Obagi and Next Health Partner to Launch “The Skin Recharge Station” Pop-Up Experience | WALD Stock News

Obagi and Next Health Partner to Launch “The Skin Recharge Station” Pop-Up Experience | WALD Stock News

Waldencast pre-market down 7.44%; Entravision Comm pre-market up 4.01%; Global Engine pre-market up 92.05%; agilon health pre-market up 56.23%; Atara Biotherapeutics pre-market up 54.56%

Price Alert

Entravision Comm

Global Engine

agilon health

Atara Biotherap

Pre-market hot trades in US stocks: Waldencast pre-market down 7.44%; Entravision Comm pre-market up 4.01%

Waldencast pre-market down 7.45%; CNS Pharma pre-market up 247.04%; Skycorp Solar pre-market up 79.76%; Global Business Travel pre-market up 48.90%

CNS Pharma

Skycorp Solar

Global Business Travel

Pre-market hot trades in US stocks: Waldencast pre-market down 7.45%, market volatility intensifies, and capital flow attracts attention

Analyst Susan Anderson of Canaccord Genuity has maintained a Buy rating on Waldencast with an unchanged price target of $2.00, citing the resolution of regulatory uncertainty and the strength of the brand portfolio. With the SEC investigation concluded, she anticipates reduced legal expenses, allowing focus on growth initiatives. Key brands like Milk Makeup and Obagi show significant global growth potential, supporting her outlook. Additionally, Alliance Global Partners also holds a Buy rating with a $2.50 price target.

Tip Ranks

Waldencast: Regulatory Overhang Cleared, Brand Growth Prospects Support Buy Rating and Unchanged $2 Price Target

Obagi Medical Unveils New Mineral Sunscreen Designed to Protect Sensitive and Post-Procedure Skin* | WALD Stock News

Obagi Medical Unveils New Mineral Sunscreen Designed to Protect Sensitive and Post-Procedure Skin* | WALD Stock News

ZSTK

In Wednesday's after-market session, several consumer staples stocks experienced notable movements. Medifast (NYSE:MED) saw a significant increase of 9.9% to $12.0, while ZeroStack (NASDAQ:ZSTK) rose 7.14% to $6.0. Other gainers included Waldencast (NASDAQ:WALD) up 5.29% to $0.8, and Sprouts Farmers Market (NASDAQ:SFM) up 3.75% to $73.8. Conversely, Planet Green Holdings (AMEX:PLAG) fell 6.5% to $1.74, with Chanson International (NASDAQ:CHSN) down 5.76% to $0.03. Overall, the session reflected mixed performance among consumer staples stocks.

benzinga_article

ZeroStack

Sprouts Farmers

Medifast

VG Consumer Stap

SPDR FD Consumer Staples

iShares US Consumer Staples ETF

First Trust NASDAQ Food & Beverage

Target

Costco Wholesale

Kroger

Maison Solutions

Borealis Foods

Planet Green

Chanson

Moolec Science SA

IP Strategy

Top Wealth

AXIL Brands

BOREALIS FOODS INC C/WTS 07/02/2029 (TO PUR COM)

MOOLEC SCIENCE SA C/WTS 30/01/2028(TO PUR COM)

12 Consumer Staples Stocks Moving In Wednesday's After-Market Session

Waldencast（WALD.US）现价 $0.8695，当日 +11.59%，盘中连续拉升，市值 1.11 亿。该公司为美容日化产品企业。受美国证监会（SEC）调查结案消息影响，投资者信心回升，推动股价飙升。近期无其他重大公告。

Movers Alert